Adiponectin is critical in determining susceptibility to depressive behaviors and has antidepressant-like activity

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 30, 2012, Pages 12248-12253

  Liu, Jing ^a   Guo, Ming ^a   Zhang, Di ^a   Cheng, Shao Ying ^a   Liu, Meilian ^a   Ding, Jun ^a   Scherer, Philipp E ^b   Liu, Feng ^a   Lu, Xin Yun ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Adipokines; Adipose tissue; Dexamethasome suppression test; Forced swim test; Tail suspension test

Indexed keywords

ADIPONECTIN; ADIPONECTIN NEUTRALIZING ANTIBODY; GLUCOCORTICOID; NEUTRALIZING ANTIBODY; RECOMBINANT ADIPONECTIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANHEDONIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE PREDISPOSITION; HAPLOINSUFFICIENCY; HELPLESSNESS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SOCIAL INTERACTION;

ABSORPTIOMETRY, PHOTON; ADIPONECTIN; ANHEDONIA; ANIMALS; ANTIBODIES, MONOCLONAL; BLOOD GLUCOSE; CORTICOSTERONE; DEPRESSION; DEXAMETHASONE; GENETIC PREDISPOSITION TO DISEASE; GLUCOCORTICOIDS; HAPLOINSUFFICIENCY; IN SITU HYBRIDIZATION; INFUSIONS, INTRAVENTRICULAR; INSULIN; LINEAR MODELS; MALE; MICE; MICE, INBRED C57BL; PSYCHOMOTOR PERFORMANCE; REAL-TIME POLYMERASE CHAIN REACTION;

MUS;

EID: 84864348004     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1202835109     Document Type: Article

References (60)

1. Ali S, Stone MA, Peters JL, Davies MJ, Khunti K (2006) The prevalence of co-morbid depression in adults with Type 2 diabetes: A systematic review and meta-analysis. Diabet Med 23:1165-1173. (Pubitemid 44600576)
2. Knol MJ, et al. (2006) Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia 49:837-845.
3. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ (2001) The prevalence of comorbid depression in adults with diabetes: A meta-analysis. Diabetes Care 24:1069-1078. (Pubitemid 33716379)
4. Andersohn F, Schade R, Suissa S, Garbe E (2009) Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus. Am J Psychiatry 166:591-598.
5. Brown LC, Majumdar SR, Johnson JA (2008) Type of antidepressant therapy and risk of type 2 diabetes in people with depression. Diabetes Res Clin Pract 79:61-67.
6. Rubin RR, et al.; Diabetes Prevention Program Research Group (2008) Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program. Diabetes Care 31:420-426.
7. Trujillo ME, Scherer PE (2005) Adiponectin - journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med 257:167-175. (Pubitemid 40193966)
8. Cnop M, et al. (2003) Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: Evidence for independent roles of age and sex. Diabetologia 46:459-469. (Pubitemid 36577787)
9. Lara-Castro C, Luo N, Wallace P, Klein RL, Garvey WT (2006) Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes 55:249-259. (Pubitemid 43343322)
10. Waki H, et al. (2003) Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem 278:40352-40363. (Pubitemid 37248604)
11. Weyer C, et al. (2001) Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86:1930-1935. (Pubitemid 32472900)
12. Pajvani UB, et al. (2003) Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity. J Biol Chem 278:9073-9085. (Pubitemid 36800387)
13. Shapiro L, Scherer PE (1998) The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor. Curr Biol 8:335-338. (Pubitemid 28159119)
14. Kusminski CM, et al. (2007) Adiponectin complexes in human cerebrospinal fluid: Distinct complex distribution from serum. Diabetologia 50:634-642. (Pubitemid 46215508)
15. Neumeier M, et al. (2007) Detection of adiponectin in cerebrospinal fluid in humans. Am J Physiol Endocrinol Metab 293:E965-E969. (Pubitemid 47535827)
16. Kubota N, et al. (2007) Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. Cell Metab 6:55-68. (Pubitemid 47007437)
17. Ebinuma H, et al. (2007) Improved ELISA for selective measurement of adiponectin multimers and identification of adiponectin in human cerebrospinal fluid. Clin Chem 53:1541-1544. (Pubitemid 47206353)
18. Qi Y, et al. (2004) Adiponectin acts in the brain to decrease body weight. Nat Med 10:524-529. (Pubitemid 38667912)
19. Zhang D, Guo M, Zhang W, Lu XY (2011) Adiponectin stimulates proliferation of adult hippocampal neural stem/progenitor cells through activation of p38 mitogen-activated protein kinase (p38MAPK)/glycogen synthase kinase 3β (GSK-3β)/β-catenin signaling cascade. J Biol Chem 286:44913-44920.
20. Yamauchi T, et al. (2003) Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423:762-769. (Pubitemid 36735700)
21. Fry M, et al. (2006) Area postrema neurons are modulated by the adipocyte hormone adiponectin. J Neurosci 26:9695-9702. (Pubitemid 44427708)
22. Leo R, et al. (2006) Decreased plasma adiponectin concentration in major depression. Neurosci Lett 407:211-213. (Pubitemid 44402873)
23. Narita K, et al. (2006) Plasma levels of adiponectin and tumor necrosis factor-alpha in patients with remitted major depression receiving long-term maintenance antidepressant therapy. Prog Neuropsychopharmacol Biol Psychiatry 30:1159-1162. (Pubitemid 43928220)
24. Lehto SM, et al. (2010) Serum adiponectin and resistin levels in major depressive disorder. Acta Psychiatr Scand 121:209-215.
25. Zeugmann S, Quante A, Heuser I, Schwarzer R, Anghelescu I (2010) Inflammatory biomarkers in 70 depressed inpatients with and without the metabolic syndrome. J Clin Psychiatry 71:1007-1016.
26. Cizza G, et al.; POWER Study Group (2010) Low 24-hour adiponectin and high nocturnal leptin concentrations in a case-control study of community-dwelling premenopausal women with major depressive disorder: The Premenopausal, Osteopenia/Osteoporosis, Women, Alendronate, Depression (POWER) study. J Clin Psychiatry 71:1079-1087.
27. Berton O, et al. (2006) Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 311:864-868. (Pubitemid 43228853)
28. Krishnan V, et al. (2007) Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell 131:391-404. (Pubitemid 47576141)
29. Yu T, et al. (2011) Cognitive and neural correlates of depression-like behaviour in socially defeated mice: An animal model of depression with cognitive dysfunction. Int J Neuropsychopharmacol 14:303-317.
30. Bardeleben U, Holsboer F (1989) Cortisol response to a combined dexamethasone-human corticotrophin-releasing hormone challenge in patients with depression. J Neuroendocrinol 1:485-488. (Pubitemid 20074394)
31. Carroll BJ, Curtis GC, Mendels J (1976) Neuroendocrine regulation in depression. II. Discrimination of depressed from nondepressed patients. Arch Gen Psychiatry 33:1051-1058.
32. Heuser I, Yassouridis A, Holsboer F (1994) The combined dexamethasone/CRH test: A refined laboratory test for psychiatric disorders. J Psychiatr Res 28:341-356. (Pubitemid 24370022)
33. Holsboer F, Bender W, Benkert O, Klein HE, Schmauss M (1980) Diagnostic value of dexamethasone suppression test in depression. Lancet 2:706. (Pubitemid 10048676)
34. Steru L, Chermat R, Thierry B, Simon P (1985) The tail suspension test: A new method for screening antidepressants in mice. Psychopharmacology (Berl) 85:367-370. (Pubitemid 15123115)
35. Porsolt RD, Le Pichon M, Jalfre M (1977) Depression: A new animal model sensitive to antidepressant treatments. Nature 266:730-732. (Pubitemid 8073804)
36. Chang HP, Wang ML, Chan MH, Chiu YS, Chen YH (2011) Antiobesity activities of indole-3-carbinol in high-fat-diet-induced obese mice. Nutrition 27:463-470.
37. HeM, et al. (2010) Reversal of obesity and insulin resistance by a non-peptidic glucagon-like peptide-1 receptor agonist in diet-induced obese mice. PLoS ONE 5:e14205.
38. Takasawa K, Kubota N, Terauchi Y, Kadowaki T (2008) Impact of increased PPAR-gamma activity in adipocytes in vivo on adiposity, insulin sensitivity and the effects of rosiglitazone treatment. Endocr J 55:767-776.
39. Fallo F, et al. (2004) Effect of glucocorticoids on adiponectin: A study in healthy subjects and in Cushing's syndrome. Eur J Endocrinol 150:339-344. (Pubitemid 38443784)
40. Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R (2002) Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun 290:1084-1089. (Pubitemid 34687474)
41. Makimura H, Mizuno TM, Bergen H, Mobbs CV (2002) Adiponectin is stimulated by adrenalectomy in ob/ob mice and is highly correlated with resistin mRNA. Am J Physiol Endocrinol Metab 283:E1266-E1271. (Pubitemid 35340634)
42. Degawa-Yamauchi M, et al. (2005) Regulation of adiponectin expression in human adipocytes: Effects of adiposity, glucocorticoids, and tumor necrosis factor alpha. Obes Res 13:662-669.
43. Pariante CM, Lightman SL (2008) The HPA axis in major depression: Classical theories and new developments. Trends Neurosci 31:464-468.
44. Holsboer F, Von Bardeleben U, Gerken A, Stalla GK, Müller OA (1984) Blunted corticotropin and normal cortisol response to human corticotropin- releasing factor in depression. N Engl J Med 311:1127. (Pubitemid 14012528)
45. Gold PW, et al. (1986) Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications. N Engl J Med 314:1329-1335. (Pubitemid 16122465)
46. Yu JG, et al. (2002) The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes 51:2968-2974.
47. Yang WS, et al. (2002) Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients. Diabetes Care 25:376-380.
48. Miyazaki Y, et al. (2004) Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients. J Clin Endocrinol Metab 89:4312-4319. (Pubitemid 39244431)
49. Pajvani UB, et al. (2004) Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem 279:12152-12162. (Pubitemid 38445780)
50. Eissa Ahmed AA, Al-Rasheed NM, Al-Rasheed NM (2009) Antidepressant-like effects of rosiglitazone, a PPARγ agonist, in the rat forced swim and mouse tail suspension tests. Behav Pharmacol 20:635-642.
51. Sepanjnia K, Modabbernia A, AshrafiM,ModabberniaMJ, Akhondzadeh S (2012) Pioglitazone adjunctive therapy formoderate-to-severemajor depressivedisorder: Randomized double-blind placebo-controlled trial. Neuropsychopharmacology, 10.1038/npp.2012.58.
52. Li X, Jope RS (2010) Is glycogen synthase kinase-3 a central modulator in mood regulation? Neuropsychopharmacology 35:2143-2154.
53. Kaidanovich-Beilin O, Milman A, Weizman A, Pick CG, Eldar-Finkelman H (2004) Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on beta-catenin in mouse hippocampus. Biol Psychiatry 55:781-784. (Pubitemid 38429867)
54. Beurel E, Song L, Jope RS (2011) Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice. Mol Psychiatry 16:1068-1070.
55. Santarelli L, et al. (2003) Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301:805-809. (Pubitemid 36962615)
56. Warner-Schmidt JL, Duman RS (2006) Hippocampal neurogenesis: Opposing effects of stress and antidepressant treatment. Hippocampus 16:239-249.
57. Nawrocki AR, et al. (2006) Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists. J Biol Chem 281:2654-2660. (Pubitemid 43845727)
58. Guo M, et al. (2012) Forebrain glutamatergic neurons mediate leptin action on depression-like behaviors and synaptic depression. Transcult Psychiatry 2:e83.
59. Liu J, Perez SM, Zhang W, Lodge DJ, Lu XY (2011) Selective deletion of the leptin receptor in dopamine neurons produces anxiogenic-like behavior and increases dopaminergic activity in amygdala. Mol Psychiatry 16:1024-1038.
60. Liu J, et al. (2010) Acute administration of leptin produces anxiolytic-like effects: A comparison with fluoxetine. Psychopharmacology (Berl) 207:535-545.